Knowledge center

Before making a commitment, do a deep dive into whether a prospect is right for your emerging biotech company.

Buy vs build decision in biomanufacturing: financial analysis should include intangibles such as loss of market share and tying up Capex early in drug development.

Navigate regulatory policies effectively and achieve regulatory compliance efficiently with discerning strategies for drug study, review, and approval.

Scale-up, tech transfer, and other areas where they can help.

Thomas Page and Parrish Galliher reflect on lessons learned from implementing the modified ballroom concept for biomanufacturing. They also share some points to consider and discuss future moves.

Considerations to help you determine which strategy best suits your process, product, and team.

Deliver groundbreaking treatments to patients in need quickly by pursuing the right funds at the right time.

Automation in process development and biomanufacturing

Sustainable supply and risk management programs: challenges and considerations

Shire and GE discuss impacts and propose solutions for successful MES implementation

View case studies and capabilities from feasibility through to biomanufacturing facility

Calculate your savings when building a single-use biomanufacturing facility